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Abstract
Introduction: Determining the etiology of Cushing’s syndrome is very challenging to endocrinologists, with most
of the difficulty arising from subtype differentiation of adrenocorticotropic hormone–dependent Cushing’s
syndrome. We present the pitfalls of evaluating a rare cause of adrenocorticotropic hormone–independent
Cushing’s syndrome in the transition period between adolescence and adulthood.
Case presentation: A sibling pair with familial isolated primary pigmented nodular adrenocortical disease is
described. The index case, a 20-year-old Chinese woman, presented with premenopausal osteoporosis with
T12 compression fracture and young hypertension. Biochemical analysis confirmed adrenocorticotropic
hormone–independent Cushing’s syndrome (elevated 0800 h plasma cortisol 808 nmol/L with suppressed
adrenocorticotropic hormone level <5 pg/ml). Computed tomography of her adrenal glands revealed a 0.7-cm
left adrenal hypodense nodule. After a left adrenalectomy, she had residual hypercortisolism (progressive weight gain,
new T10 compression fracture, and not glucocorticoid-dependent postoperatively). Completion of contralateral
adrenalectomy was performed upon recognition of typical histologic characteristics of primary pigmented nodular
adrenocortical disease found in an initial left adrenalectomy specimen. Similarly, her younger brother developed
adrenocorticotropic hormone–independent Cushing’s syndrome at age 18 years, with typical cushingoid habitus, but
no osteoporosis or hypertension. His adrenal computed tomographic scans showed micronodularities over bilateral
adrenal glands. He was successfully treated with bilateral adrenalectomy. Screening for Carney’s complex and PRKAR1A
gene mutation was negative. Signs and symptoms of Cushing’s syndrome resolved after bilateral adrenalectomy for
both patients. They were placed on lifelong glucocorticoid and mineralocorticoid replacement therapy and long-term
surveillance for Carney’s complex.
Conclusions: The cases of these two patients illustrate the difficulties involved in diagnosing primary pigmented
nodular adrenocortical disease, a variant of adrenocorticotropic hormone–independent Cushing’s syndrome that is
managed with bilateral adrenalectomy. A high index of suspicion for this disease is needed, especially in adolescents
with adrenocorticotropic hormone–independent Cushing’s syndrome who have a significant family history,
features of Carney’s complex, and no resolution of Cushing’s syndrome after unilateral adrenalectomy. Patients
with primary pigmented nodular adrenocortical disease can either have bilateral/multiple adrenal nodules or
normal adrenal glands visualized by computed tomography. Long-term surveillance is imperative in patients
with confirmed Carney’s complex and in those who have not undergone complete genetic testing to exclude
this hereditary disorder.
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Introduction
Endogenous Cushing’s syndrome (CS) is a rare disorder
with an incidence of 1.2 cases/1 million/year [1]. Primary
pigmented nodular adrenocortical disease (PPNAD) is a
very rare cause of endogenous CS in adults, but it is
more common in adolescence and early adulthood [2].
We report the cases of two siblings with CS secondary
to familial isolated PPNAD and discuss pitfalls of diag-
nosing CS in patients in the transition zone between
pediatric and adult endocrinology.
Case presentations
Patient 1
A 20-year-old Chinese woman presented to an orthopedic
surgeon at our hospital with persistent back pain. She was
then referred to an endocrinologist for assessment of verte-
bral fragility fracture. She complained of progressive weight
gain (7 kg within 4 weeks), acne, easy bruising, proximal
myopathy, and oligomenorrhea of 1 years’ duration. Her
physical examination revealed that she was hypertensive
(blood pressure 150/100 mmHg) and short in stature
(height 1.47 m), and her body mass index (BMI) was
22.2 kg/m2. She had thin skin; dorsocervical/supraclavicu-
lar fat pads; central obesity; acanthosis nigricans; moon
facies; and purplish striae on the abdomen, inner thighs,
and popliteal fossae. She was not hirsute. Her secondary
sexual characteristics and visual fields were normal. A
provisional diagnosis of hypercortisolism was made.
Her blood test results excluded diabetes mellitus
and electrolyte abnormalities. Her hormone tests revealed
hypercortisolemia (0800 h plasma cortisol 808 nmol/L),
and a suppressed ACTH level <5 pg/ml. Her total
serum testosterone was mildly elevated (Table 1).
ACTH-independent CS was confirmed after a 48-h,
Table 1 Investigation results
Investigations Patient 1 Patient 2 Reference range
Liddle’s test N/A 24-h UFC (predexamethasone) 3923 nmol/L 58–805 nmol/L
24-h UFC (postdexamethasone) 4168 nmol/L
HbA1c (NGSP) 5.1 % 5.1 % <6.5 %
fT4 12.9 pmol/L 16.7 pmol/L 11–23 pmol/L
TSH 0.67 mIU/L 0.72 mIU/L 0.5–5.5 mIU/L
IGF-1 268 ng/ml 282 ng/ml 116–350 ng/ml (patient 1)
193–731 ng/ml (patient 2)
GH 2.3 ng/ml 0.2 ng/ml 0.0–3.0 ng/ml
LH 1.4 IU/L 5.8 IU/L Follicular phase 1.9–12.5 IU/L
Midcycle 8.7–76.3 IU/L
Luteal phase 0.5–16.9 IU/L
Male 1.5–9.3 IU/L




Testosterone 3.4 nmol/L 13.0 nmol/L Female 0.5–2.6 nmol/L
Male 9.3–23.0 nmol/L
DHEA-S 0.07 μg/dl 0.04 μg/dl Female 0.02–0.30 μg/dl
Male 0.10–0.40 μg/dl
Estradiol 153 pg/ml N/A Follicular phase 20–144 pg/ml
Midcycle 64–357 pg/ml
Luteal phase 56–214 pg/ml
Prolactin 123 mIU/L 127 mIU/L Female 59–619 mIU/L
Male 44–373 mIU/L
Thyroid US Normal Well-defined right thyroid cystic nodule with soft
tissue component (1.1 × 1.0 × 1.4 cm), increased
peripheral vascularity
N/A not applicable HbA1c hemoglobin A1c, NGSP National Glycohemoglobin Standardization Program, DHEA-S dehydroepiandrosterone sulfate, US ultrasound,
IGF-1 insulin-like growth factor 1, GH growth hormone, LH luteinizing hormone, FSH follicle-stimulating hormone, fT4 free thyroxine, TSH thyroid-stimulating
hormone, UFC urinary free cortisol
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2-mg, low-dose dexamethasone suppression test (LDDST)
failed to suppress endogenous cortisol secretion (0800 h
post-LDDST plasma cortisol 621 nmol/L). A 0.7-cm left
adrenal hypodense nodule was identified by performing
adrenal computed tomography (CT) and was reported as
an adenoma (Fig. 1a). An x-ray of her thoracolumbar
spine disclosed a T12 compression fracture. Dual-energy
bone densitometry (DXA) revealed low bone mineral
density (BMD) with Z-scores of −4.5 (L1-L2) and −3.2
(femoral neck).
Preoperatively, she was treated with spironolactone
(for hypertension and edema), ketoconazole (to inhibit
steroidogenesis), and teriparatide, cholecalciferol, and
calcium supplements (for low BMD and vertebral
fracture). A left retroperitoneoscopic adrenalectomy was
performed 4 weeks later. Her hypertension and edema
resolved after surgery. She was commenced on physio-
logic hydrocortisone replacement therapy in anticipation
of transient hypocortisolism due to suppression of the
contralateral adrenal gland. One month postoperatively,
her 0800 h serum cortisol measured before the morning
dose of hydrocortisone was 384 nmol/L. She continued
to gain weight, had persistent oligomenorrhea, and de-
veloped a new T10 compression fracture with 2-cm
height reduction. Reevaluation after cessation of hydro-
cortisone showed failed suppression of endogenous
plasma cortisol with a 1-mg overnight LDDST (0800 h
plasma cortisol 248 nmol/L). By then, histology of the
excised left adrenal gland unexpectedly revealed pigmen-
ted nodular adrenocortical hyperplasia (Fig. 2). The
patient’s preoperative CT was reviewed, confirming
micronodularity with multiple nodules of the left adrenal
Fig. 1 Computed tomography of the adrenal glands and gross pathology of the lesions. Patient 1: Computed tomographic scan of her adrenal
glands shows a nodular left adrenal gland with hypodense lesions (red arrow) and a normal right adrenal gland (a), and histologic specimen
shows cut surface of left adrenal gland with multiple brown nodules (c). Patient 2: Computed tomographic scan shows a hypodense
micronodular appearance of both adrenal glands (red arrows) (b), and gross histologic specimens reveal adrenal hyperplasia with multiple
pale brown nodules (d)
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gland, which had been missed initially. She had no der-
matologic features (lentigines/blue nevi) or murmurs
suggestive of cardiac myxoma characteristic of Carney’s
complex (CNC). The results of ultrasound (US) of her
breasts and pelvis, as well as of transthoracic echocardi-
ography (TTE) and other tests performed to screen for
features of CNC, were negative (Table 1).
A complete right retroperitoneoscopic adrenalectomy
was scheduled. Histology confirmed the initial diagnosis
of PPNAD. Lifelong hydrocortisone and fludrocortisone
replacement therapy was commenced after surgery. Her
postoperative 0800 h serum cortisol level was <6 nmol/L.
Repeat DXA 2 months after surgery showed improvement
of her BMD with Z-scores of −3.1 (L1-L2) and −2.6
(femoral neck). Teriparatide and cholecalciferol/calcium
carbonate were continued for 18 months. She is now
normotensive, has reestablished a normal menstrual cycle,
and no longer has a cushingoid habitus.
Patient 2
The younger sibling of patient 1, an 18-year-old Chinese
man, presented to us 3 months after his sister’s first sur-
gery. He had a 2-year history of purple striae and com-
plained of rapid weight gain (4 kg in 4 weeks). His
physical examination revealed that his height was 1.63 m
and his BMI was 23.1 kg/m2. He had no lentigines/blue
nevi. He was normotensive but had moon facies and
purple striae (bilateral axillae, popliteal fossae, and
waist). He did not have a goiter, proximal myopathy, or
and dorsocervical/supraclavicular fat pads. His second-
ary sexual characteristics were normal, with no testicular
mass evident.
His blood tests excluded diabetes mellitus and electro-
lyte abnormalities. His hormone tests revealed sup-
pressed ACTH (<5 pg/ml) and failed suppression of
endogenous plasma cortisol after 1-mg overnight
LDDST (0800 h serum cortisol 624 nmol/L). Subsequent
LDDST confirmed CS (0800 h plasma cortisol 513
nmol/L). Liddle’s test revealed a paradoxical increase in
urinary free cortisol (UFC) (Table 1). DXA disclosed sec-
ondary osteoporosis [Z-scores of −3.2 (spine) and −2.5
(femoral neck)]. Adrenal CT revealed a diffusely en-
larged left adrenal gland and normal-sized nodular right
adrenal gland (Fig. 1b). The results of TTE and US scans
of the testes as well as other screening (Table 1) for
features of CNC were unremarkable. His thyroid US
revealed a well-defined nodule, which fine-needle aspir-
ation confirmed as a benign follicular nodule.
A bilateral retroperitoneoscopic adrenalectomy was
performed, with ketoconazole used as bridging therapy.
The results of patient 2’s histologic examination were
similar to those of patient 1, establishing the diagnosis of
PPNAD (Fig. 2). His postoperative 0800 h serum cortisol
level was <6 nmol/L, and he was commenced on lifelong
hydrocortisone and fludrocortisone replacement therapy.
His signs and symptoms of CS resolved after 6 months.
Follow-up of both patients
Both patients were given a steroid card and counseled
on sick-day rules. Their parents were not in a consan-
guineous marriage. The family tree was shown in Fig. 3.
There was no family history of CNC. Genetic tests for
the PRKAR1A mutation were sent to the National Insti-
tutes of Health with the patients’ written informed con-
sent. The results of DNA sequencing for PRKAR1A gene
point mutation and deletion/duplication were negative for
both siblings. Unfortunately, they declined further genetic
testing despite genetic counseling.
Fig. 2 Adrenal histology [hematoxylin and eosin stain; original
magnifications ×4 (a) and ×10 (b)]. Multiple nodules (2–5 mm in
diameter) containing brown pigment can be seen in the adrenal
cortex, composed of cells with round to ovoid nuclei with eosinophilic
cytoplasm. Many cells with vacuolated, foamy cytoplasm were noted,
also in addition to marked vascular congestion. Immunohistochemistry
showed positivity for synaptophysin and vimentin, focal positivity for
chromogranin A and S100, and a negative result for cytokeratin
antibody MNF116
Patient 1 Patient 2
Overnight DST
negative
Fig. 3 Family tree for this sibling pair. *refused screening for CS
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Discussion
Determining the etiology of endogenous CS is one of the
most complex challenges that confronts an endocrin-
ologist (Fig. 4) [3, 4]. The causes of CS are broadly
subclassified into ACTH-independent (20 %) and
ACTH-dependent (80 %) categories. ACTH-independent
CS is most commonly due to unilateral adrenocortical
tumors. Only 10–15 % of ACTH-independent CS is
caused by bilateral adrenal hyperplasia (BAH) [2], which
comprises PPNAD and ACTH-independent macronodu-
lar adrenal hyperplasia (AIMAH). Of the two, PPNAD is
more common [2]. In a 10-year adult population-based
study in Denmark, only 2 (1.4 %) of 139 patients with
CS were diagnosed with isolated PPNAD [1]. In children,
BAH may account for a greater proportion of ACTH-
independent CS. The authors of a retrospective review
of 105 patients with CS (3–18 years old) found that
23.8 % had primary adrenal disease, and 84 % of
these had BAH [5]. In this report, we present a rare
cause of ACTH-independent CS in the transition
zone from pediatric to adult endocrinology.
PPNAD, which has an autosomal dominant inheritance
pattern, can be sporadic or familial (isolated or more com-
monly associated with CNC) [6]. It has a bimodal age distri-
bution with peaks before age 5 years and, more commonly,
in the second and third decades of life. Our two patients
presented at ages 20 and 18 years, respectively.
The signs and symptoms of PPNAD are insidious yet
progressive, and diagnosis is delayed in most patients
[6]. Three different phenotypes of PPNAD [overt (84 %),
subclinical (6 %), and latent (10 %)] have been described
[6, 7]. Our sibling pair presented with overt PPNAD.
Compared with other causes of CS, osteoporosis (39 % of
PPNAD) and growth retardation (29 % of PPNAD) [6]
are more prevalent. CS is one of the common causes
of young hypertension, which is generally defined as
BP ≥140/90 mmHg in patients <40 years old [8]. However,
hypertension tends to occur in only 55–85 % of patients
with CS [9]. Thus, in our two patients, the younger
brother did not develop hypertension as seen in the
older sister.
The 6-day Liddle’s test helps to differentiate PPNAD
from other causes of ACTH-independent CS. Most
patients have a >50 % paradoxical increase in UFC and
17-hydroxysteroid secretion due to overexpression of
glucocorticoid (GC) receptors in PPNAD nodules [7, 10].
An atypical 6 % paradoxical increase in UFC was observed
in patient 2, which was suggestive of PPNAD in the con-
text of a positive family history.
In the context of ACTH-independent CS, PPNAD
should be suspected in patients with multiple nodules in
one or both adrenal glands, bilateral solitary nodules on
either side [11], unilateral/bilateral enlargement of the
adrenal gland, or normal adrenal glands bilaterally visu-
alized by imaging [12]. About half of PPNAD patients
have normal-sized adrenal glands seen on CT scans, as
in our sibling pair [12, 13]. Other differential diagnoses
for bilateral adrenal masses/abnormalities in the setting
Fig. 4 An algorithm for the diagnosis and management of Cushing’s syndrome. Surgical therapy is the mainstay of treatment in Cushing’s
syndrome. Adapted from [3, 4, 19]
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of suppressed ACTH are AIMAH (usually associated
with a macronodular appearance), bilateral cortisol-
secreting adenomas/adenolipomas [10], or a unilateral
adrenal adenoma with contralateral nonfunctioning inci-
dentaloma. Multiple micronodules observed on CT
scans give rise to a “strings of beads” appearance, which
is typically seen between ages 12 and 18 years [12]. After
age 18 years, patients with PPNAD can even have ad-
renal macronodules (2–3 cm), which are indistinguish-
able radiologically from AIMAH and pituitary Cushing’s
syndrome with BAH [12].
Adrenal CT and/or magnetic resonance imaging do
not afford the ability to determine the functionality of
adrenal lesions in ACTH-independent CS with bilateral
adrenal masses. Adrenal venous sampling (AVS) may
serve as an adjunct in this setting, helping in the
decision-making of whether a unilateral or bilateral
adrenalectomy is required. Young et al. performed
AVS in ten patients and reported that an adrenal vein
to peripheral vein cortisol gradient >6.5 was consistent
with a cortisol-secreting adenoma and that a cortisol
lateralization ratio of ≤2.0 was suggestive of bilateral
cortisol hypersecretion [14]. AVS therefore has a po-
tential role in the management of ACTH-independent
CS, especially when CT shows bilateral adrenal nodu-
larity. However, limited experience (due to the rarity of
this condition), variations in protocol, and interpretation
of results (successful catheterization and lateralization)
currently hamper the routine use of AVS in ACTH-
independent CS.
The characteristic macroscopic appearance of PPNAD
is small to normal-sized adrenal glands with multiple
small cortical pigmented nodules. Microscopically, the
nodules consist of large cortical cells with eosinophilic
cytoplasm, large hyperchromatic nuclei and prominent
nucleoli, and atrophy between nodules [15]. Synapto-
physin immunostaining helps to distinguish PPNAD
nodules from surrounding normal adrenal cortex. Our
patients’ histologies were typical of PPNAD.
Given its rarity, PPNAD might be overlooked. It is
often recognized postoperatively based on histology. In
retrospect, there were a few salient points to suggest bi-
lateral adrenal disease rather than a unilateral adrenal
adenoma in patient 1. Review of her initial adrenal CT
showed micronodularities, especially over the left ad-
renal gland, which is not seen in patients with unilateral
adrenal adenoma. Also, despite partial resolution of her
symptoms, she had residual hypercortisolism; that is, she
continued to gain weight, developed a new T10 com-
pression fracture, and never had GC deficiency postop-
eratively. Our experience has taught us that all efforts
should be made to look for other features of CNC and
to take a detailed family history, focusing on CNC in
young patients with ACTH-independent CS.
CNC is a multiple neoplasia syndrome associated with
clustering of skin tumors and pigmented lesions, myx-
omas, schwannomas, and endocrine tumors. PPNAD is
the most common endocrine tumor associated with
CNC, occurring in 60 % of patients with CNC [16].
Recognition of CNC is crucial for genetic screening
recommendation, as it is an autosomal dominant trait
disorder [17]. In addition, lifelong screening for asso-
ciated features is indicated in patients diagnosed with
CNC [17].
A definite diagnosis of CNC is made if at least two
major criteria are present or one major criterion is met
in an affected first-degree relative with CNC, or if the
index case or relative has a PRKAR1A mutation [15].
The major criteria for a diagnosis of CNC are listed
below [17]:
 Spotty skin pigmentation over the lips, conjunctiva,
inner and/or outer canthi, and vaginal or penile
mucosa
 Cutaneous, mucosal myxoma
 Cardiac myxoma
 Breast myxomatosis
 Endocrine overactivity (for example, PPNAD,
acromegaly)
 Large-cell calcifying Sertoli cell tumor (LCCSCT)
 Thyroid carcinoma or multiple hypoechoic nodules
on thyroid US
 Psammomatous melanotic schwannoma
 Multiple blue nevi
 Multiple breast ductal adenoma
 Osteochondromyxoma
The PRKAR1A gene, located on chromosome 17q22-
24, encodes the regulatory type Iα subunit of protein
kinase A, an inactivating mutation that is responsible for
the disease in nearly half of CNC kindred [16]. Phospho-
diesterase 11A (PDE11A gene) and phosphodiesterase
8B (PDE8B gene) mutations, as well as chromosome
2p16 mutations, have also been identified in patients
with isolated PPNAD [18].
The results for DNA sequencing for PRKAR1A gene
point mutation and deletion and/or duplication were
negative in our sibling pair. Unfortunately, the patients’
family declined Whole Exome Sequencing (WES), the
next step in detailed DNA analysis of all chromosomes.
Among patients with CNC, 30 % do not have a
PRKAR1A gene mutation. Salpea et al. demonstrated
PRKAR1A haploinsufficiency secondary to 17q24.2-
q24.3 deletions surrounding the affected gene in 21.6 %
of PRKAR1A mutation-negative patients [18].
In the absence of a PRKAR1A gene mutation, our pa-
tients do not fit the criteria for CNC. At present, they
each meet only one major criterion. The most likely
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diagnosis is familial isolated PPNAD. As they declined
WES, it is still possible that they have CNC but have
not yet developed associated features enumerated in
Stratakis et al.’s major criteria [17].
The treatment of choice for PPNAD is bilateral adre-
nalectomy, especially in overt PPNAD as in our sibling
pair. Laparoscopic adrenalectomy is favored over an
open surgical method in this era, as it is associated with
shorter hospital stay, fewer perioperative complications,
and earlier return to normal activity [19]. In Carney and
Young’s series of 88 patients, 65 % were cured after bi-
lateral adrenalectomy [7]. Of the patients who under-
went subtotal and/or unilateral adrenalectomy, 35 % had
persistence and/or recurrence of CS and required
completion of total adrenalectomy [7]. However, the
aforementioned retrospective review found that sub-
total and/or unilateral adrenalectomy might be consid-
ered in asymptomatic or mildly symptomatic patients
with PPNAD.
As we were unable to exclude non-PRKAR1A gene
mutations in our patients, we determined that future
management should incorporate long-term surveillance
for CNC. The presence of a benign follicular nodule in
patient 2 warrants periodic thyroid US at 6–18-month
intervals [20]. If thyroid carcinoma develops, it tends to
present at a younger age and with a higher incidence of
multifocality, invasion, and local recurrence [21]. Regular
US of the testes is imperative for patient 2, as males with
CNC tend to develop LCCSCT, which blocks seminifer-
ous tubules, causing infertility. Serial DXA will be per-
formed to monitor the expected improvement in BMD
in both patients postoperatively. In patient 1, there was
only partial improvement of her BMD after surgery. We
hope that 18-month therapy with teriparatide will help
rebuild bone density and eventually result in a normal
peak bone mass. Bisphosphonates were not used in her
case, owing to concern with regard to its safety in young
women of childbearing age. Monitoring for Nelson’s syn-
drome is crucial for patients who undergo bilateral adre-
nalectomy. Of note, Carney and Young did not report
any case of Nelson’s syndrome after bilateral adrenalec-
tomy in patients with CNC [7].
Conclusions
The two reported cases illustrate the difficulties involved
in diagnosing PPNAD, a variant of ACTH-independent
CS that more commonly presents with osteoporosis in
young patients and is ideally managed by bilateral adre-
nalectomy. A high index of suspicion is needed, espe-
cially in adolescents with ACTH-independent CS, a
family history of CS, multiple and/or bilateral adrenal
nodules, features of CNC, and failure of resolution of CS
after unilateral adrenalectomy. The diagnosis of PPNAD
in patients without a family history or an index case in a
yet-to-be-identified kindred is harder. Long-term sur-
veillance for CNC is imperative in patients with con-
firmed CNC and those who have not undergone
complete genetic testing to exclude CNC.
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